Related Experiment Video
Updated: Jul 17, 2026

Cell-Based Drug Screening for Inhibitors of Autophagy Related 4B Cysteine Peptidase
Published on: June 30, 2023
Synthesis and biological evaluation of phosphonate derivatives as autotaxin (ATX) inhibitors
Peng Cui1, Jose L Tomsig, William F McCalmont
1Department of Chemistry, University of Virginia, McCormick Road, Charlottesville, VA 22904, USA. pc3n@virginia.edu
Abstract:
Autotaxin (ATX) is an autocrine motility factor that promotes cancer cell invasion, cell migration, and angiogenesis. ATX, originally discovered as a nucleotide phosphodiesterase, is known now to be responsible for the lysophospholipid-preferring phospholipase D activity in plasma. As such, it catalyzes the production of lysophosphatidic acid (LPA) from lysophophatidylcholine (LPC). ATX is thus an attractive drug target; small molecular inhibitors might be efficacious in slowing the spread of cancers. With this study we have generated a series of beta-keto and beta-hydroxy phosphonate derivatives of LPA, some of which are potent ATX inhibitors.
Insights
Researchers developed novel phosphonate derivatives that inhibit autotaxin (ATX), an enzyme crucial for cancer cell invasion and spread. These compounds show promise as potential therapeutics for slowing cancer progression.
Area of Science:
- Biochemistry
- Medicinal Chemistry
- Oncology
Background:
- Autotaxin (ATX) is a key enzyme involved in cancer progression, promoting cell invasion, migration, and angiogenesis.
- ATX catalyzes the production of lysophosphatidic acid (LPA), a lipid mediator implicated in various cancers.
- The enzymatic activity of ATX makes it a significant target for developing novel anti-cancer therapies.
Purpose of the Study:
- To design and synthesize novel phosphonate derivatives based on lysophosphatidic acid (LPA).
- To evaluate the potential of these derivatives as inhibitors of autotaxin (ATX) activity.
- To explore the therapeutic utility of ATX inhibitors in combating cancer spread.
Main Methods:
- Synthesis of a series of beta-keto and beta-hydroxy phosphonate derivatives.
- Characterization of the synthesized compounds.
- Assay of inhibitory activity against autotaxin (ATX).
Main Results:
- Several beta-keto and beta-hydroxy phosphonate derivatives of LPA were successfully synthesized.
- Some of the synthesized compounds demonstrated potent inhibition of autotaxin (ATX) activity.
- These findings highlight the potential of these novel compounds as ATX inhibitors.
Conclusions:
- Novel phosphonate derivatives of LPA have been developed as potential autotaxin (ATX) inhibitors.
- The synthesized compounds show promise for therapeutic intervention in cancers where ATX plays a critical role.
- Further research into these compounds could lead to new strategies for inhibiting cancer cell invasion and metastasis.
More Related Videos
19:44Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
Published on: May 30, 2012
08:31Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
Published on: December 1, 2020
Related Concept Videos
ATP Synthase: Mechanism
Allosteric Proteins-ATCase
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
Protein Kinases and Phosphatases
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include: